Serveur d'exploration Tocilizumab - Merge (Accueil)

Index « AffPaysInc.i » - entrée « Department of Rheumatology »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Department of Respiratory Medicine Tokyo Metropolitan Tama Medical Center Fuchu-shi Tokyo Japan. < Department of Rheumatology < Department of Rheumatology and  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 7.
Ident.Authors (with country if any)Title
002960 (2013) A. Meyer [France] ; A. Theulin ; E. Chatelus ; C. Sordet ; R.-M. Javier ; B. Geny [France] ; J.-E. Gottenberg ; J. SibiliaTHU0412 Reactive hyperemia index (RHI) is associated with macrovascular disease and lung disease in systemic sclerosis
002A55 (2013) Y. Yonemoto ; K. Okamura ; K. Takeuchi ; M. Matsushita [Japon] ; T. Kaneko ; T. Kobayashi ; T. Aramaki [Japon] ; K. TakagishiTHU0094 Direct comparison of four biological agents in bio-naïve rheumatoid arthritis patients
002D03 (2013) H. U. Scherer ; Y. Rombouts ; E. Ewing [Pays-Bas] ; L. A. Van De Stadt [Pays-Bas] ; M. H. Selman [Pays-Bas] ; A. M. Deelder [Pays-Bas] ; T. W. Huizinga ; M. Wuhrer [Pays-Bas] ; D. Van Schaardenburg [Pays-Bas] ; R. E. ToesOP0189 Anti-Citrullinated Protein Antibody Specific FC Glycosylation Patterns in Patients with Arthralgia
003033 (2013) M. Can ; F. Alibaz-Öner ; B. Ilhan ; S. Öner ; N. Inanc ; T. Ergun ; G. Mumcu [Turquie] ; H. DireskeneliAB0765 Quality of life and fatigue in patients with behcet’s disease
003201 (2013) Y. Yonemoto ; K. Okamura ; K. Takeuchi ; M. Matsushita [Japon] ; T. Kaneko ; T. Kobayashi ; T. Aramaki [Japon] ; K. TakagishiAB0340 Is the concomitant use of methotrexate with tocilizumab necessary in bio-naive rheumatoid arthritis patients?
003223 (2013) M. Herly ; K. Stengaard-Pedersen ; P. Vestergaard ; J. P Denphandt [Danemark] ; M. Stergaard [Danemark] ; P. Junker [Danemark] ; M. L. Hetland [Danemark] ; K. H Rslev-Petersen [Danemark] ; T. EllingsenAB0316 Patient’s global assessment of general health by vas at baseline predicts ACR/EULAR remission after 3, 6 and 12 month’s of efficient treatment in DMARD- and steroid naÏve early rheumatoid arthritis patients. The danish cimestra-study
003333 (2013) Odilia Bj Corneth ; Adriana Mc Mus ; Patrick S. Asmawidjaja ; Maarten D. Brem ; Franka Luk ; Wendy Dankers ; Rudi W. Hendriks [Pays-Bas] ; Erik LubbertsA3.9 IL-17RA Signalling is Essential for Collagen Induced Arthritis Development

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Merge
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/AffPaysInc.i -k "Department of Rheumatology" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/AffPaysInc.i  \
                -Sk "Department of Rheumatology" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Merge
   |type=    indexItem
   |index=    AffPaysInc.i
   |clé=    Department of Rheumatology
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021